Stephen J. Haggarty, PhD

Stephen J. Haggarty, PhD

Harvard University

H-index: 70

North America-United States

About Stephen J. Haggarty, PhD

Stephen J. Haggarty, PhD, With an exceptional h-index of 70 and a recent h-index of 53 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Neuroscience, Drug Discovery, Neuropsychiatric Disease, Brain Plasticity, Epigenetics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Compounds for tau protein degradation

129. The Effects of Novel Small Molecules in a Preclinical Model of Positive Affective State

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Inhibitors of histone deacetylase

Targeted degraders of aberrant tau based on the pet tracer pbb3

Prolyylioligopeptidaasin estäjistä apua muistisairauksien pysäyttämiseen?

Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders

Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing

Stephen J. Haggarty, PhD Information

University

Position

Harvard Medical School, MGH

Citations(all)

32359

Citations(since 2020)

13896

Cited By

24497

hIndex(all)

70

hIndex(since 2020)

53

i10Index(all)

161

i10Index(since 2020)

140

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Stephen J. Haggarty, PhD Skills & Research Interests

Neuroscience

Drug Discovery

Neuropsychiatric Disease

Brain Plasticity

Epigenetics

Top articles of Stephen J. Haggarty, PhD

Title

Journal

Author(s)

Publication Date

Compounds for tau protein degradation

2019/1/17

129. The Effects of Novel Small Molecules in a Preclinical Model of Positive Affective State

Biological Psychiatry

Sarina Mohanty

Amanda Roberts

Daniel Levy

Stephen Haggarty

Pablo Lapuerta

2024/5/15

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Scientific Reports

Zachary C Rosenthal

Daniel M Fass

N Connor Payne

Angela She

Debasis Patnaik

...

2024/4/20

Inhibitors of histone deacetylase

2022/10/11

Targeted degraders of aberrant tau based on the pet tracer pbb3

2023/5/4

Prolyylioligopeptidaasin estäjistä apua muistisairauksien pysäyttämiseen?

Duodecim

Tony S Eteläinen

M Catarina Silva

Johanna K Uhari-Väänänen

Francesca De Lorenzo

Maria H Jäntti

...

2023

Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders

2021/11/23

Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing

Nature Communications

Lien D Nguyen

Zhiyun Wei

M Catarina Silva

Sergio Barberán-Soler

Jiarui Zhang

...

2023/11/21

Cholesterol Dysregulation Drives Seed-Dependent Tau Aggregation in Patient Stem Cell-Derived Models of Tauopathy

bioRxiv

Morrie Lam

Szu-Yu Kuo

Surya Reis

Jason E Gestwicki

M Catarina Silva

...

2023

A Cdk5-derived peptide inhibits Cdk5/p25 activity and improves neurodegenerative phenotypes

Proceedings of the National Academy of Sciences

Ping-Chieh Pao

Jinsoo Seo

Audrey Lee

Oleg Kritskiy

Debasis Patnaik

...

2023/4/18

Arrdc1-mediated microvesicle-based delivery to the nervous system

2023/7/20

Improved Protocol for Reproducible Human Cortical Organoids Reveals Early Alterations in Metabolism with MAPT Mutations

BioRxiv

Taylor Bertucci

Kathryn R Bowles

Steven Lotz

Le Qi

Katherine Stevens

...

2023

A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy

Science translational medicine

Tony S Eteläinen

M Catarina Silva

Johanna K Uhari-Väänänen

Francesca De Lorenzo

Maria H Jäntti

...

2023/4/12

Targeted aberrant alpha-synuclein species and induced ubiquitination and proteosomal clearance via co-recruitment of an e3-ligase system

2023/7/20

Small Molecule Regulators of microRNAs in Human iPSC-derived Neurons Identified by High-Throughput Screen Coupled High-Throughput Sequencing

Journal of Biological Chemistry

Lien Nguyen

Zhiyun Wei

M Catarina Silva

Sergio Barberán-Soler

Christina Muratore

...

2023/1/1

Photoswitchable HDAC inhibitors

2023/3/7

Bipolar disorder-iPSC derived neural progenitor cells exhibit dysregulation of store-operated Ca2+ entry and accelerated differentiation

Molecular Psychiatry

Tristen Hewitt

Begüm Alural

Manali Tilak

Jennifer Wang

Natalina Becke

...

2023/7/4

Small Molecule Inducers of Neuroprotective miR-132 Identified by HTS-HTS in Human iPSC-derived Neurons

bioRxiv

Lien D Nguyen

Zhiyun Wei

M Catarina Silva

Sergio Barberán-Soler

Rosalia Rabinovsky

...

2022/11/1

A bidirectional competitive interaction between circHomer1 and Homer1b within the orbitofrontal cortex regulates reversal learning

Cell reports

Alexander K Hafez

Amber J Zimmerman

Grigorios Papageorgiou

Jayapriya Chandrasekaran

Stephen K Amoah

...

2022/1/18

Brain-specific deletion of GIT1 impairs cognition and alters phosphorylation of synaptic protein networks implicated in schizophrenia susceptibility

Molecular psychiatry

Daniel M Fass

Michael C Lewis

Rushdy Ahmad

Matthew J Szucs

Qiangge Zhang

...

2022/8

See List of Professors in Stephen J. Haggarty, PhD University(Harvard University)